Results 31 to 40 of about 8,882 (195)
Clinical periodontal diagnosis
Periodontology 2000, EarlyView., 2023 Abstract Periodontal diseases include pathological conditions elicited by the presence of bacterial biofilms leading to a host response. In the diagnostic process, clinical signs such as bleeding on probing, development of periodontal pockets and gingival recessions, furcation involvement and presence of radiographic bone loss should be assessed prior ...
Giovanni E. Salvi +5 more
wiley +1 more source
JEADV Clinical Practice, 2023 Bullous pemphigoid is a rare complication of immune checkpoint inhibitor treatment. We report a case of pembrolizumab‐induced bullous pemphigoid in a patient with malignant melanoma and concomitant cutaneous squamous cell carcinoma that regressed.
Shin Iinuma +2 more
doaj +1 more source
Bullous Pemphygoid and Novel Therapeutic Approaches
Biomedicines, 2022 Bullous pemphigoid is a subepidermal blistering disease associated with autoantibodies (auto-ab) to BP180 and BP230 which affects elderly patients, predominately.
Giovanni Marco D’Agostino +10 more
doaj +1 more source
Resolution in bullous pemphigoid [PDF]
Seminars in Immunopathology, 2019 AbstractPemphigoid diseases are a group of autoimmune blistering skin diseases defined by an immune response against certain components of the dermal-epidermal adhesion complex. They are prototypical, autoantibody-driven, organ-specific diseases with the emergence of inflammatory skin lesions dependent on the recruitment of immune cells, particularly ...
Christian D. Sadik, Enno Schmidt
openaire +2 more sources
Acta Dermato-Venereologica, 2021 Bullous pemphigoid constitutes a rare dermatological immune-related adverse event of programmed cell death protein 1 (PD-1)/programmed cell death ligand 1 (PD-L1) inhibitors.
Aikaterini Tsiogka +2 more
doaj +1 more source
Correlation between bullous pemphigoid and type 2 inflammation
Pifu-xingbing zhenliaoxue zazhi, 2022 Bullous pemphigoid (BP) is one of the common autoimmune blister diseases that mainly affects the elderly. Most bullous pemphigoid patients have obvious symptom of pruritus, accompanied by elevated levels of serum total IgE, peripheral blood eosinophils ...
Yao ZHOU +6 more
doaj +1 more source
A Systematic Review of Drug-Induced Pemphigoid
Acta Dermato-Venereologica, 2020 Bullous pemphigoid is an autoimmune subepithelial disease characterised by pruritus followed by urticarial plaques and finally bullae on the skin and mucosa.
Matthew J. Verheyden +2 more
doaj +1 more source
European Journal of Case Reports in Internal Medicine, 2022 Bullous pemphigoid is a rare autoimmune dermatologic disease that usually occurs in the elderly. Mucous membrane lesions occur in about 10–35% of patients and are almost always limited to the oral mucous membrane. Esophageal involvement is very rare (4% of cases) and usually presents with chest pain, dysphagia, and odynophagia, though patients are ...
Castelo Branco, Catarina +2 more
openaire +4 more sources
Lower Extremity Salvage in the Setting of Bullous Pemphigoid Exacerbation: A Case Report
Plastic and Reconstructive Surgery, Global Open, 2021 Summary:. Bullous pemphigoid is an autoimmune blistering disease where patients suffer from painful bullae, often covering large portions of the skin and requiring management with immune-suppression.
Samara E. Pollock, MD +5 more
doaj +1 more source
Pemphigus and bullous pemphigoid
The Lancet, 1999 Pemphigus and bullous pemphigoid are distinct autoimmune blistering diseases that are characterised by the presence of autoantibodies directed against specific adhesion molecules of the skin and mucous membranes. The comparison and contrast of molecular mechanism of blister formation of these two diseases provide a rational diagnostic and therapeutic ...
H C, Nousari, G J, Anhalt
openaire +2 more sources